CA1183473A - Vaccins contre la brochite infectieuse des volailles et procede de preparation - Google Patents

Vaccins contre la brochite infectieuse des volailles et procede de preparation

Info

Publication number: CA1183473A
Authority: CA; Canada
Prior art keywords: cnctc; virus; vaccines; under; infectious bronchitis
Prior art date: 1979-11-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000439896A

Other languages

English (en)

Inventor

Peter Apontoweil

Manfred M. Krasselt

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Gist Brocades NV

Original Assignee

Gist Brocades NV

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-11-30

Filing date

1983-10-27

Publication date

1985-03-05

1979-11-30 Priority claimed from NL7908687A external-priority patent/NL7908687A/nl

1980-09-09 Priority claimed from NL8005083A external-priority patent/NL8005083A/nl

1980-11-28 Priority claimed from CA000365730A external-priority patent/CA1184115A/fr

1983-10-27 Application filed by Gist Brocades NV filed Critical Gist Brocades NV

1985-03-05 Application granted granted Critical

1985-03-05 Publication of CA1183473A publication Critical patent/CA1183473A/fr

Status Expired legal-status Critical Current

Links

229960005486 vaccine Drugs 0.000 title abstract description 49
208000015181 infectious disease Diseases 0.000 title abstract description 18
230000002458 infectious effect Effects 0.000 title abstract description 13
206010006451 bronchitis Diseases 0.000 title abstract description 11
244000144977 poultry Species 0.000 title abstract description 10
238000002360 preparation method Methods 0.000 title description 14
238000000034 method Methods 0.000 title description 13
230000008569 process Effects 0.000 title description 7
244000005700 microbiome Species 0.000 claims abstract description 3
241000711450 Infectious bronchitis virus Species 0.000 claims abstract 5
238000004519 manufacturing process Methods 0.000 abstract description 3
241000700605 Viruses Species 0.000 description 83
241000287828 Gallus gallus Species 0.000 description 20
235000013330 chicken meat Nutrition 0.000 description 16
235000013601 eggs Nutrition 0.000 description 15
239000000463 material Substances 0.000 description 14
238000012360 testing method Methods 0.000 description 10
239000012071 phase Substances 0.000 description 9
238000004108 freeze drying Methods 0.000 description 8
235000013594 poultry meat Nutrition 0.000 description 8
239000000725 suspension Substances 0.000 description 7
201000010099 disease Diseases 0.000 description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
239000012530 fluid Substances 0.000 description 6
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
210000002257 embryonic structure Anatomy 0.000 description 5
241000271566 Aves Species 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
238000003556 assay Methods 0.000 description 4
FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 4
239000003795 chemical substances by application Substances 0.000 description 4
238000001816 cooling Methods 0.000 description 4
150000002500 ions Chemical class 0.000 description 4
239000000203 mixture Substances 0.000 description 4
238000012545 processing Methods 0.000 description 4
230000000241 respiratory effect Effects 0.000 description 4
239000005723 virus inoculator Substances 0.000 description 4
108010088751 Albumins Proteins 0.000 description 3
102000009027 Albumins Human genes 0.000 description 3
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
229930195725 Mannitol Natural products 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
238000001914 filtration Methods 0.000 description 3
239000000594 mannitol Substances 0.000 description 3
229960001855 mannitol Drugs 0.000 description 3
235000010355 mannitol Nutrition 0.000 description 3
238000006386 neutralization reaction Methods 0.000 description 3
239000003921 oil Substances 0.000 description 3
238000000746 purification Methods 0.000 description 3
229960005322 streptomycin Drugs 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
210000000605 viral structure Anatomy 0.000 description 3
JDRAOGVAQOVDEB-KTKRTIGZSA-N (3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl) (z)-octadec-9-enoate Chemical compound OC1COC2C(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC21 JDRAOGVAQOVDEB-KTKRTIGZSA-N 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
241000711573 Coronaviridae Species 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
241000726306 Irus Species 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
239000008346 aqueous phase Substances 0.000 description 2
230000002238 attenuated effect Effects 0.000 description 2
VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
239000003995 emulsifying agent Substances 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
230000003053 immunization Effects 0.000 description 2
230000002163 immunogen Effects 0.000 description 2
229940031551 inactivated vaccine Drugs 0.000 description 2
230000002779 inactivation Effects 0.000 description 2
238000011534 incubation Methods 0.000 description 2
238000002955 isolation Methods 0.000 description 2
210000004877 mucosa Anatomy 0.000 description 2
210000003101 oviduct Anatomy 0.000 description 2
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
229920000053 polysorbate 80 Polymers 0.000 description 2
229960000380 propiolactone Drugs 0.000 description 2
239000003381 stabilizer Substances 0.000 description 2
210000003437 trachea Anatomy 0.000 description 2
238000002255 vaccination Methods 0.000 description 2
230000029812 viral genome replication Effects 0.000 description 2
241000711404 Avian avulavirus 1 Species 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
ONYFNWIHJBLQKE-ZETCQYMHSA-N N(6)-acetimidoyl-L-lysine Chemical compound CC(=N)NCCCC[C@H](N)C(O)=O ONYFNWIHJBLQKE-ZETCQYMHSA-N 0.000 description 1
241000702244 Orthoreovirus Species 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
241000183024 Populus tremula Species 0.000 description 1
241001501970 Prionailurus bengalensis Species 0.000 description 1
NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
230000010530 Virus Neutralization Effects 0.000 description 1
NWGKJDSIEKMTRX-BFWOXRRGSA-N [(2r)-2-[(3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-BFWOXRRGSA-N 0.000 description 1
LUXUAZKGQZPOBZ-SAXJAHGMSA-N [(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O LUXUAZKGQZPOBZ-SAXJAHGMSA-N 0.000 description 1
230000004520 agglutination Effects 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
125000002947 alkylene group Chemical group 0.000 description 1
210000001643 allantois Anatomy 0.000 description 1
210000001691 amnion Anatomy 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000008859 change Effects 0.000 description 1
210000000991 chicken egg Anatomy 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
230000001804 emulsifying effect Effects 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
244000144992 flock Species 0.000 description 1
ODKNJVUHOIMIIZ-RRKCRQDMSA-N floxuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 ODKNJVUHOIMIIZ-RRKCRQDMSA-N 0.000 description 1
235000013305 food Nutrition 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
210000003292 kidney cell Anatomy 0.000 description 1
230000003902 lesion Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
229960003255 natamycin Drugs 0.000 description 1
NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 1
235000010298 natamycin Nutrition 0.000 description 1
239000004311 natamycin Substances 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
239000002245 particle Substances 0.000 description 1
244000052769 pathogen Species 0.000 description 1
239000010773 plant oil Substances 0.000 description 1
-1 polyoxyethylene Polymers 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
210000002345 respiratory system Anatomy 0.000 description 1
230000004044 response Effects 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
235000002020 sage Nutrition 0.000 description 1
230000000405 serological effect Effects 0.000 description 1
241000894007 species Species 0.000 description 1
230000002311 subsequent effect Effects 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
238000010998 test method Methods 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
239000007762 w/o emulsion Substances 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Landscapes

Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

CA000439896A 1979-11-30 1983-10-27 Vaccins contre la brochite infectieuse des volailles et procede de preparation Expired CA1183473A (fr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
NL7908687A NL7908687A (nl)	1979-11-30	1979-11-30	Infectieuze bronchitis vaccins voor pluimvee en werkwijze voor het bereiden van dergelijke vaccins.
NL79,08687		1979-11-30
NL8005083A NL8005083A (nl)	1980-09-09	1980-09-09	Infectieuze bronchitis vaccins voor pluimvee en werkwijze voor het bereiden van dergelijke vaccins.
NL80,05083		1980-09-09
CA000365730A CA1184115A (fr)	1979-11-30	1980-11-28	Vaccins contre la bronchite infectieuse des volailles et procede de preparation

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000365730A Division CA1184115A (fr)	1979-11-30	1980-11-28	Vaccins contre la bronchite infectieuse des volailles et procede de preparation

Publications (1)

Publication Number	Publication Date
CA1183473A true CA1183473A (fr)	1985-03-05

Family

ID=27166903

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
CA000439896A Expired CA1183473A (fr)	1979-11-30	1983-10-27	Vaccins contre la brochite infectieuse des volailles et procede de preparation
CA000439895A Expired CA1184116A (fr)	1979-11-30	1983-10-27	Vaccins contre la bronchite infectieuse des volailles et procede de preparation

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
CA000439895A Expired CA1184116A (fr)	1979-11-30	1983-10-27	Vaccins contre la bronchite infectieuse des volailles et procede de preparation

Country Status (1)

Country	Link
CA (2)	CA1183473A (fr)

1983
- 1983-10-27 CA CA000439896A patent/CA1183473A/fr not_active Expired
- 1983-10-27 CA CA000439895A patent/CA1184116A/fr not_active Expired

Also Published As

Publication number	Publication date
CA1184116A (fr)	1985-03-19

Legal Events

Date	Code	Title	Description
2002-03-05	MKEX	Expiry
2023-05-26	MKEX	Expiry	Effective date: 20020305

Publication	Publication Date	Title
EP0073547B1 (fr)	1985-09-11	Vaccin pour la volaille contre la bronchite infectieuse, vaccins combinés contre la bronchite infectieuse, procédé d'obtention de ces vaccins et souche virale de bronchite infectieuse
DE60012042T2 (de)	2005-07-07	Entepneumovirus und entsprechendes impfstoff
EP0030063B1 (fr)	1983-08-24	Vaccins contre la bronchite infectieuse pour la volaille, vaccins combinés contre la bronchite infectieuse; procédé de préparation de tels vaccins; procédé pour prévenir la bronchite infectieuse et souches de virus de la bronchite infectieuse
US4357320A (en)	1982-11-02	Infectious bronchitis vaccine for poultry
US4302444A (en)	1981-11-24	Vaccines for immunizing egg-laying birds against Egg Drop disease, preparation of said vaccines, and method of use of said vaccines
JP2718518B2 (ja)	1998-02-25	マイコプラズマワクチン
JPH07121873B2 (ja)	1995-12-25	鳥感染性気管支炎ワクチン
Rosales et al.	1989	Pathogenicity of recent isolates of infectious bursal disease virus in specific-pathogen-free chickens: protection conferred by an intermediate vaccine strain
US4500638A (en)	1985-02-19	Infectious bronchitis virus strain
JP3945842B2 (ja)	2007-07-18	弱毒性ニューカッスル病ウイルスワクチン
CA1183473A (fr)	1985-03-05	Vaccins contre la brochite infectieuse des volailles et procede de preparation
EP0009277B1 (fr)	1984-04-18	Vaccin combiné actif contre la maladie de Newcastle et contre la baisse de la ponte causée par des virus du genre adéno, procédé de préparation, souches de virus du genre adéno et de la maladie de Newcastle
USRE31830E (en)	1985-02-12	Infectious bronchitis vaccine for poultry
JP2887251B2 (ja)	1999-04-26	伝染性気管支炎ウイルス培養物及びそれからのワクチン
USRE32423E (en)	1987-05-19	Infectious bronchitis virus strain
USRE34013E (en)	1992-07-28	Infectious bronchitis vaccine for poultry
HU203674B (en)	1991-09-30	Process for producing weakened turtle rhinotracheitis virus and vaccine containing them
JPS6244528B2 (fr)	1987-09-21
KR910004365B1 (ko)	1991-06-26	돼지 오제스키병 바이러스의 외피단백질을 이용한 유성백신 제조방법
NL8005083A (nl)	1982-04-01	Infectieuze bronchitis vaccins voor pluimvee en werkwijze voor het bereiden van dergelijke vaccins.
Coria et al.	1972	Immune Response in Chickens to Infectious Bronchitis Virus, Strain 33. III. Beta-Propiolactone-Inactivated and Live-Virus Vaccines Compared by Statistical Methods
Makesh et al.	1998	Efficacy of bursal derived killed infectious bursal disease vaccine in experimental chicks
Cunningham	1978	AVIAN INFECTIOUS BRONCHITIS: PATHOBIOLOGY AND IMMUNITY